Hardev Pandha
MD, PhD, FRCP
Professor of Medical Oncology
👥Biography 个人简介
Hardev Pandha has developed coxsackievirus A21 (CAVATAK) as an oncolytic agent and led early-phase clinical trials in melanoma and bladder cancer, demonstrating activity through ICAM-1-mediated viral entry. His research has characterized the immune-stimulatory consequences of coxsackievirus oncolysis and explored combinations with pembrolizumab in phase I/II studies. He is a leading proponent of intravesical oncolytic virus therapy for bladder cancer.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Hardev Pandha 的研究动态
Follow Hardev Pandha's research updates
留下邮箱，当我们发布与 Hardev Pandha（University of Surrey）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment